Evista (chemical name: raloxifene) is a SERM approved by the U.S. Food and Drug Administration (FDA) to: 1  reduce the risk of hormone-receptor-positive breast cancer in postmenopausal women who haven't been diagnosed but are at higher-than-average risk for disease.
Types of paper ICT Express publishes original research papers in English in the fields of ICT convergence, platform technologies, communication networks, and device technologies. ICT Express accepts short-length (up to 4 pages in double columns and additional 2 pages will be allowed with over page charge (100USD/1page)) high-quality, original articles in Latex or Word format. Sample manuscript can be downloaded here.
After 33 volumes, Statistical Methodology will be discontinued as of 31st December 2016. At this point the possibility to submit manuscripts has been suspended. We encourage authors to visit Elsevier's Journal Finder Tool ( http://journalfinder.elsevier.com ) to identify other potential journals for their work.